Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin

J Neuroimmunol. 2008 Mar;195(1-2):28-35. doi: 10.1016/j.jneuroim.2008.01.001. Epub 2008 Feb 15.

Abstract

We report the construction of a fusion protein comprising the extracellular domain of myelin oligodendrocyte glycoprotein (MOG) and a truncated version of Pseudomonas aeruginosa exotoxin A (ETA'). The chimeric immunotoxin targeted MOG-reactive B-lymphocytes by binding selectively to the appropriate receptors, leading to internalization and apoptosis of the target cells. The functionality of the immunotoxin was tested on a MOG-sensitive murine hybridoma cell line and ex vivo on freshly isolated splenocytes from transgenic IgH(MOG) mice. These data demonstrate, for the first time, the specific cytotoxicity of a MOG-containing recombinant immunotoxin expressed in bacteria towards MOG-reactive B-lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Cell Line, Transformed
  • Cell Proliferation
  • Cell Survival
  • Dose-Response Relationship, Immunologic
  • Flow Cytometry / methods
  • Humans
  • Hybridomas
  • Lymphocyte Depletion*
  • Myelin Proteins
  • Myelin-Associated Glycoprotein / genetics*
  • Myelin-Associated Glycoprotein / toxicity
  • Myelin-Oligodendrocyte Glycoprotein
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / toxicity*
  • Transfection

Substances

  • MOG protein, human
  • Mog protein, mouse
  • Myelin Proteins
  • Myelin-Associated Glycoprotein
  • Myelin-Oligodendrocyte Glycoprotein
  • Recombinant Fusion Proteins